Sentara Infusion Services: Drug Recall
Recall #D-0281-2023 · 12/27/2022
Class II: Risk
Recall Details
- Recall Number
- D-0281-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Sentara Infusion Services
- Status
- Completed
- Date Initiated
- 12/27/2022
- Location
- Chesapeake, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 bags
Reason for Recall
Lack of sterility assurance
Product Description
CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
Distribution Pattern
Dispensed to Patients Nationwide.
Other Recalls by Sentara Infusion Services
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.